In this guide
- The short answer
- What endotoxin actually is
- Why endotoxin is tested at all
- The LAL test and the horseshoe-crab cascade
- The three LAL methods: gel-clot, turbidimetric, chromogenic
- Endotoxin units, sensitivity and the maximum valid dilution
- How an endotoxin limit is set
- Recombinant Factor C and the move off crab blood
- The standards: USP, European Pharmacopoeia and the FDA
- The rabbit pyrogen test and the monocyte activation test
- Endotoxin on a certificate of analysis
- What this guide does not establish
- Frequently asked questions
- References
The short answer
Endotoxin testing measures the amount of bacterial endotoxin — lipopolysaccharide shed from the outer membrane of Gram-negative bacteria — in a sample. The standard method, the bacterial endotoxins test (BET), uses the clotting reaction of horseshoe-crab amebocyte lysate (LAL), or a recombinant Factor C reagent, and reports the result in endotoxin units (EU). It is a test for one specific class of contaminant, not a measure of purity, identity or sterility.
The reason the test exists is that endotoxin is both dangerous and durable. The molecule is a potent pyrogen: in a living body it triggers fever, inflammation and, at high enough exposure, a lethal collapse called endotoxic shock. It is also heat-stable, so it outlives the bacteria that made it and passes straight through the sterilisation steps that kill living organisms. A material can be sterile and still carry endotoxin, which is why endotoxin gets a dedicated test of its own.
That test comes in two broad lineages. The older one, the Limulus amebocyte lysate (LAL) test, uses an extract of horseshoe-crab blood cells whose natural job is to clot around invading bacteria; endotoxin switches on an enzyme cascade in the lysate that ends in a gel, a colour or a cloudiness that can be measured and compared against a reference standard. The newer one replaces the crab extract with recombinant Factor C, a single laboratory-made copy of the cascade’s first enzyme, read out by fluorescence. The rest of this guide works through the chemistry of endotoxin, the mechanics of each method, how the numbers are defined and limited, and what an endotoxin result on a research certificate of analysis can and cannot tell you.
The moleculeWhat endotoxin actually is
Endotoxin is lipopolysaccharide (LPS), the large molecule that makes up much of the outer membrane of Gram-negative bacteria. Understanding the test starts with understanding that this molecule is a structural part of a living cell wall, not a secreted toxin, which is exactly why it is so widespread and so hard to avoid.
Lipopolysaccharide is built from three covalently linked parts.[9] The outermost is the O-antigen, a repeating sugar chain that is highly variable between strains and gives each its serological identity — a single species such as Escherichia coli can present well over a hundred different O-antigen structures. Beneath it sits the core oligosaccharide, a less variable region containing characteristic sugars such as heptose and KDO (3-deoxy-D-manno-oct-2-ulosonic acid). Anchored in the membrane itself is lipid A, a phosphorylated glucosamine disaccharide carrying several fatty-acid chains. Lipid A is the hydrophobic foot that holds the whole molecule in the membrane, and it is the part from which the toxicity is largely derived.[9] LPS is the most abundant molecule on the surface of most Gram-negative bacteria, contributing up to roughly 80 percent of the outer membrane in organisms such as E. coli and Salmonella.[9]
What makes endotoxin medically important is the way the body reacts to lipid A. LPS is the prototypical endotoxin because it binds the CD14/TLR4/MD2 receptor complex on monocytes, macrophages and other immune cells, driving the release of pro-inflammatory cytokines and other mediators.[9] The discovery that Toll-like receptor 4 is the LPS sensor earned a share of the 2011 Nobel Prize in Physiology or Medicine.[7][9] That signalling is what produces fever and, when LPS floods the bloodstream, the cascade of endotoxemia and endotoxic shock; a dose on the order of one microgram per kilogram is enough to induce shock in a human.[9] Because the reaction is driven by the conserved lipid A core rather than by any one strain’s variable sugar chain, an endotoxin test does not need to know which bacterium the contamination came from — it detects the shared, bioactive part they all carry.
RationaleWhy endotoxin is tested at all
Endotoxin is tested because it is the single most important source of pyrogenic contamination in anything made by, grown in, or exposed to water and biological material, and because no other quality measurement catches it. A purity assay, an identity assay and a sterility test can all pass on a sample that is heavily contaminated with endotoxin.
The gap exists for two reasons. First, endotoxin is remarkably heat-stable: ordinary autoclaving and sterile filtration remove or kill organisms, but they do not reliably destroy the LPS those organisms leave behind. Removing or inactivating endotoxin is a separate task, called depyrogenation, usually achieved by prolonged dry heat, by specific chemical treatment, or by removal during purification. Second, endotoxin is ubiquitous wherever Gram-negative bacteria can grow, above all in water and on glassware and equipment, so it is introduced by the process rather than made by it. These two facts — that endotoxin survives sterilisation and that it is everywhere — are why regulators require a distinct bacterial endotoxins test on injectable medicines, on medical devices that contact blood or cerebrospinal fluid, and on the water and components used to make them.
For research materials the same logic applies in a laboratory key rather than a clinical one. Endotoxin is one of the most common confounders in cell-culture and in-vitro work: because it activates immune and inflammatory pathways at very low concentrations, a few endotoxin units of contamination can swamp the biological signal an experiment is trying to read. That is the reason endotoxin appears as a line on some research certificates of analysis, distinct from the purity and identity numbers covered in Peptide Purity Grades Explained and What Is Mass Spectrometry.
MechanismThe LAL test and the horseshoe-crab cascade
The LAL test works by hijacking a defence reaction that evolved in the horseshoe crab, whose blood clots around invading Gram-negative bacteria. The reagent is Limulus amebocyte lysate, prepared from the amebocytes — the blood cells — of the Atlantic horseshoe crab Limulus polyphemus; an equivalent reagent made from Asian species, Tachypleus amebocyte lysate (TAL), is used in parts of Asia.[15][16]
The crab’s amebocytes carry granules of clotting proteins that are released when the cell meets endotoxin, and those proteins act in sequence as an enzyme cascade.[8][15] The entry point is a protein called Factor C, which is the cascade’s endotoxin sensor: when lipid A binds it, Factor C becomes an active protease.[8][16] Activated Factor C switches on Factor B; activated Factor B converts a proclotting enzyme into the active clotting enzyme; and the clotting enzyme cleaves a soluble protein called coagulogen into coagulin, which assembles into a gel.[8][15] Each step amplifies the one before it, so a very small amount of endotoxin produces a large, measurable response — the feature that makes the reaction so sensitive. The structural biology of the two protease zymogens in this cascade was worked out in detail only recently.[8]
The cascade has one well-known quirk that matters for interpreting results. Conventional lysate also contains a second sensor, Factor G, which responds not to endotoxin but to (1,3)-beta-D-glucans — sugars shed by moulds and by some filters and cellulosic materials — and Factor G activation feeds into the same clotting pathway.[15][16] A beta-glucan can therefore produce a positive LAL reaction that has nothing to do with endotoxin, a false positive that laboratories control by using glucan-blocking buffers or Factor G-depleted lysates. This quirk becomes relevant again when we reach recombinant reagents, which avoid it entirely.
MethodsThe three LAL methods: gel-clot, turbidimetric, chromogenic
USP General Chapter <85> recognises three techniques for the bacterial endotoxins test, and they differ in what they measure at the end of the cascade rather than in the biology that drives it.[1] All three compare the sample’s reaction against a dilution series of a reference standard endotoxin.
The gel-clot technique is the original and the simplest: it is based on clotting of the lysate in the presence of endotoxin.[1] A sample is mixed with lysate, incubated undisturbed — typically at about 37 °C for an hour — and then inverted; a firm gel that holds in place when the tube is turned over is a positive result, while anything that merely thickens or clouds is negative.[15] Run as a limit test it gives a simple pass or fail at a chosen sensitivity; run as a quantitative test it is titrated to an endpoint across serial dilutions. Because it needs no instrument, it is also the referee method: USP <85> specifies that in the event of doubt or dispute, the final decision is made on the gel-clot limit test unless a monograph says otherwise.[1]
The turbidimetric technique measures the cloudiness that develops as coagulin forms, relating turbidity to endotoxin concentration.[1] It can be run as an endpoint assay, reading absorbance after a fixed incubation, or as a kinetic assay that measures the time taken to reach a set turbidity (the onset time) or the rate at which turbidity develops.[1] The chromogenic technique replaces coagulogen with a synthetic peptide carrying a colour-forming group; when the clotting enzyme cleaves that substrate it releases a chromophore, and the colour is read against concentration, again in either endpoint or kinetic form.[1][15] The two photometric methods are quantitative and well suited to plate readers and automation, which is why most high-throughput endotoxin testing today is kinetic-chromogenic.
| Technique | What is measured | Readout | Typical use |
|---|---|---|---|
| Gel-clot | Formation of a solid clot of coagulin | Visual: firm gel on tube inversion (pass/fail or endpoint titration) | Limit tests; the referee method in disputes |
| Turbidimetric | Cloudiness as coagulin assembles | Absorbance or transmission; endpoint or kinetic (onset time / rate) | Quantitative testing on a plate reader |
| Chromogenic | Colour released when the clotting enzyme cleaves a synthetic substrate | Absorbance of the chromophore; endpoint or kinetic | High-throughput quantitative testing |
| Recombinant Factor C (rFC) | Activation of a single recombinant Factor C by endotoxin | Fluorescence from a fluorogenic substrate | Animal-free quantitative testing (USP <86>) |
Endotoxin units, sensitivity and the maximum valid dilution
Endotoxin is reported in endotoxin units, not in mass, and the reason is that endotoxins differ in potency from one source to another. A unit of biological activity is a fairer common currency than a microgram, so the test is calibrated to a defined standard rather than weighed.
An endotoxin unit (EU) expresses endotoxin activity relative to a reference standard. The working standards used in a laboratory are calibrated against the USP Endotoxin Reference Standard, which is itself calibrated to the WHO International Standard for endotoxin; one USP endotoxin unit equals one International Unit (IU).[1] Results are then quoted in EU per millilitre for a solution or EU per milligram for a solid, so that a measured value can be set against a defined limit.
Two further quantities govern how the test is actually run. The first is the reagent’s labelled sensitivity, written with the Greek letter lambda: in the gel-clot method lambda is the lowest endotoxin concentration in EU/mL that still produces a clot (a common value is 0.125 EU/mL), and in the photometric methods it is the lowest concentration on the standard curve.[1][15] Before a lysate lot is used it must be confirmed, by running standard endotoxin at twice, once, half and a quarter of lambda in replicate and checking that the geometric-mean endpoint falls between 0.5 and 2 times the labelled value.[15]
The second is the maximum valid dilution (MVD), the most a sample may be diluted and still allow the endotoxin limit to be detected.[1] USP <85> defines it as the endotoxin limit multiplied by the concentration of the sample solution, divided by lambda.[1] Dilution is not a cosmetic step: many samples interfere with the cascade, either inhibiting it or enhancing it, and the standard way to overcome that interference is to dilute the sample — up to the MVD but no further — until it no longer distorts the recovery of a known endotoxin spike. A valid photometric assay must recover a spike within 50 to 200 percent of the amount added, which is how a laboratory proves the sample matrix is not hiding or faking endotoxin.[15] A negative result, it is worth stressing, means endotoxin was not detected at the test’s effective threshold, not that the sample contains none.[15]
LimitsHow an endotoxin limit is set
An endotoxin test only means something against a limit, and the limit is derived from how much of the product a body could receive, not chosen arbitrarily. The framework comes from the pharmaceutical world, and it is worth seeing because it explains the units in which endotoxin specifications are written.
For a parenteral drug, USP <85> sets the endotoxin limit by the formula K / M, where K is a threshold pyrogenic dose of endotoxin per kilogram of body weight and M is the maximum recommended bolus dose of product per kilogram of body weight; when a product is infused continuously or injected frequently, M becomes the maximum total dose given in a single hour.[1] The chapter fixes K at 5 USP-EU per kilogram of body weight for any route of administration other than intrathecal, and at 0.2 EU per kilogram for the intrathecal route, where the nervous system is far more sensitive.[1] The limit for a given product therefore tightens as its maximum dose rises, and it is quoted in whatever unit the monograph uses — EU/mL, EU/mg, or EU per unit of biological activity.[1]
Medical devices are limited in similar terms. FDA guidance describes device endotoxin limits such as 0.5 EU/mL or 20 EU per device for products contacting the cardiovascular and lymphatic systems, and a far stricter 0.06 EU/mL or 2.15 EU per device for anything contacting cerebrospinal fluid.[6]
| Context | Endotoxin threshold (K or limit) | Why |
|---|---|---|
| Parenteral, non-intrathecal (K) | 5 EU/kg | Threshold pyrogenic dose per kg; limit = K/M |
| Intrathecal route (K) | 0.2 EU/kg | Direct contact with the central nervous system |
| Device, cardiovascular / lymphatic | 0.5 EU/mL or 20 EU/device | Blood-contacting device limit (FDA) |
| Device, cerebrospinal-fluid contact | 0.06 EU/mL or 2.15 EU/device | CNS-contacting device limit (FDA) |
These figures belong to the regulated world of approved medicines and devices; laboratory research chemicals carry no such requirement. They are set out here because they are the clearest published statement of how an endotoxin number is judged, and because a research buyer reading an endotoxin value on a certificate is looking at the same kind of unit.
The recombinant routeRecombinant Factor C and the move off crab blood
The most significant recent change in endotoxin testing is the arrival of reagents that reproduce the crab’s sensing chemistry without the crab. These were developed for two linked reasons: to remove a pharmaceutical supply chain’s dependence on a wild animal, and to address the conservation and animal-welfare concerns around harvesting horseshoe-crab blood.
The key reagent is recombinant Factor C (rFC). Rather than extract the whole cascade from blood cells, the gene for Factor C — the cascade’s endotoxin biosensor — is cloned and expressed in cultured cells, yielding a single, consistent protein.[11][14] rFC has been commercially available since 2003 and is based on the same Limulus Factor C protein produced in genetically modified cells, read out not with a clot but with a synthetic fluorogenic substrate that lights up when endotoxin activates the enzyme.[11][16] The foundational work on using recombinant Factor C to bind endotoxin was published by Ding, Ho and colleagues from the late 1990s onward.[10][11][12] Because rFC contains no Factor G, (1,3)-beta-D-glucans cannot trigger it, so the beta-glucan false positives that complicate conventional LAL simply do not occur.[16] A later refinement, the recombinant cascade reagent (rCR), rebuilds the full cascade from recombinant Factor C, Factor B and proclotting enzyme and reads out chromogenically, mirroring the conventional chromogenic method with animal-free components.
The conservation argument behind these reagents is substantial. Horseshoe crabs are classed as vulnerable in the United States and endangered in parts of Asia, and their eggs are a critical food source for migratory shorebirds.[14] Biomedical bleeding returns many crabs to the water, but studies of post-bleeding mortality have reported figures well above the industry’s pre-2008 claim of under 3 percent — one 2010 study of female crabs reported mortality around 22 percent for animals returned immediately and about 30 percent for those held overnight as in commercial practice.[13][16] The case for a synthetic alternative has been argued directly in the conservation literature.[12] For a laboratory, the practical upshot is that an animal-free reagent can match the performance of LAL while removing both the supply risk and the ecological cost; by one assessment of the available evidence, the rFC test is no worse than the LAL test.[16]
StandardsThe standards: USP, European Pharmacopoeia and the FDA
Endotoxin testing is one of the most tightly standardised measurements a laboratory runs, and knowing which document says what helps when reading a specification. The compendial and regulatory texts fall into a small, stable set.
In the United States, the method lives in USP General Chapter <85>, Bacterial Endotoxins Test, which defines the three techniques, the reference standard, the sensitivity confirmation, the MVD and the K/M limit calculation described above.[1] Its recombinant companion, USP General Chapter <86>, Bacterial Endotoxins Test Using Recombinant Reagents, was approved by the USP Microbiology Expert Committee in 2024 and became official in USP–NF in May 2025; it gives recombinant reagents such as rFC and rCR their own compendial standing rather than treating them as alternative methods needing extra justification.[2][16] The older rabbit test remains in USP General Chapter <151>, Pyrogen Test.[6]
In Europe, the equivalent of <85> is European Pharmacopoeia chapter 2.6.14, Bacterial endotoxins, and the recombinant method has its own chapter, 2.6.32, Test for bacterial endotoxins using recombinant factor C, which the European Directorate for the Quality of Medicines made available on 1 July 2020.[5][14] The FDA, for its part, does not publish a separate method but defers to these compendial chapters: its guidance Pyrogen and Endotoxins Testing: Questions and Answers points industry to USP <85> and related standards for how to calculate limits and interpret results, and addresses alternative methods on a case-by-case basis.[6] The practical message is that an endotoxin specification citing “USP <85>” or “Ph. Eur. 2.6.14” is naming a precisely defined procedure, not a generic idea of a test.
Related testsThe rabbit pyrogen test and the monocyte activation test
The bacterial endotoxins test is not the only way to look for pyrogens, and it is useful to know where it sits among its neighbours, because each of the others answers a slightly different question. The distinction that matters is between an endotoxin test and a pyrogen test: endotoxin is one kind of pyrogen, the commonest and most dangerous, but not the only one.
The rabbit pyrogen test, USP <151>, is the historical reference. It injects the test material into rabbits and watches for a rise in body temperature, so it responds to any pyrogen, endotoxin or not. It is slow, expensive and uses animals, which is why LAL displaced it for most products after the FDA licensed LAL in 1977.[16] FDA guidance notes that the rabbit test can still be the more appropriate choice where non-endotoxin pyrogens are a concern, or where sample interference cannot be overcome by dilution up to the MVD.[6]
The monocyte activation test (MAT) is the modern, cell-based successor to the rabbit test. It exposes human monocytes to the sample and measures the inflammatory cytokines they release, so, like the rabbit, it detects the full range of pyrogens — including non-endotoxin ones — but in a human-relevant, animal-free format. FDA guidance treats the monocyte activation test as an example of an alternative assay that it will consider on a case-by-case basis with product-specific validation.[6] For most routine work, though, the bacterial endotoxins test remains the default, because endotoxin is the pyrogen that matters most and the BET measures it faster and more cheaply than anything else.
On the COAEndotoxin on a certificate of analysis
Where endotoxin appears on a certificate of analysis, it sits apart from the purity and identity lines, and reading it correctly means knowing that it answers a different question from the rest of the report. Purity by HPLC and identity by mass spectrometry describe what the molecule is and how much of the material is the target; an endotoxin value describes a biological contaminant that neither of those tests can see.
An endotoxin result is typically written as a value in EU/mg or EU/mL against a limit, with the method named — for example a kinetic-chromogenic LAL assay, or a recombinant Factor C assay, performed to USP <85> or <86>. A complete entry should state the method and the limit, not just a pass, because the number is only interpretable against the sensitivity and dilution the laboratory used, as the sections above describe. It is also worth remembering what an endotoxin figure does not cover: it says nothing about chemical purity, counterion content or net peptide content, which are the subjects of What Is Net Peptide Content and Peptide Impurities Explained, and it is specific to the lot tested.
For reference, Patriot Labs is a first-responder-owned, US-based company whose every batch is tested by an independent US laboratory, with the certificate of analysis published on the product page; the purity and identity figures on that certificate come from HPLC and mass spectrometry, the two measurements described in What Is HPLC and What Is Mass Spectrometry. Endotoxin testing, where it is performed, is a separate assay from those two, run and reported by the methods set out here.
Honest limitsWhat this guide does not establish
This guide is an educational account of what endotoxin is and how it is measured. Several limits are worth stating plainly.
- It describes a test, not any specific product. Whether a given lot has been endotoxin-tested, and what value it returned, is a property of that lot and its certificate of analysis, not something that can be inferred from a compound’s name or from this page.
- The limits cited are regulatory. The K/M calculation, the 5 and 0.2 EU/kg thresholds and the device limits apply to approved medicines and devices under pharmacopoeial and FDA frameworks; research-grade laboratory chemicals carry no equivalent legal requirement, and the figures are given only as a reference point.[1][6]
- Nothing here concerns use in a person or animal. The pyrogenic effects of endotoxin are described to explain why the test exists and why its limits are set; they are not statements about any research compound, and this guide does not describe how to use any product.
- Nothing here describes where any peptide is made. The chemistry of endotoxin and the mechanics of the assay are general; they are not a claim about the origin, process or contamination status of any specific material.
Frequently asked questions
What is endotoxin testing?
Endotoxin testing measures the amount of bacterial endotoxin, which is lipopolysaccharide shed from the outer membrane of Gram-negative bacteria, in a sample. The standard method is the bacterial endotoxins test (BET), which uses the clotting reaction of horseshoe-crab amebocyte lysate (LAL) or a recombinant Factor C reagent and reports the result in endotoxin units (EU). It is a test for one specific class of contaminant, not a general measure of purity or sterility.
What is the LAL test?
The LAL test is the bacterial endotoxins test performed with Limulus amebocyte lysate, a reagent made from the blood cells of the horseshoe crab. Endotoxin activates an enzyme cascade in the lysate that ends in the formation of a gel or a measurable color or turbidity, and the strength of that reaction is compared against a reference standard to quantify endotoxin. It replaced the slower rabbit pyrogen test for most products after the FDA licensed it in 1977.
What is the difference between the LAL test and recombinant Factor C?
LAL is a natural lysate harvested from horseshoe crabs that contains the whole clotting cascade. Recombinant Factor C (rFC) is a single, laboratory-produced copy of Factor C, the first enzyme that cascade uses to sense endotoxin, and it is read with a fluorescent substrate rather than a clot. Because rFC is made by cell culture rather than drawn from animals, it does not depend on horseshoe crab blood, and because it lacks Factor G it does not give the false positives that beta-glucans can cause in LAL.
What are endotoxin units (EU)?
An endotoxin unit (EU) is a measure of endotoxin activity defined against a reference standard rather than by weight, because different endotoxins differ in potency. One USP endotoxin unit is calibrated to the WHO International Standard for endotoxin and is equal to one International Unit (IU). Results are expressed in EU per milliliter or EU per milligram so they can be compared to a defined limit.
Is a sterile sample the same as an endotoxin-free sample?
No. Sterility means no living microorganisms are present. Endotoxin is a heat-stable molecule from the outer membrane of Gram-negative bacteria, and it survives after the bacteria that produced it are dead. A sample can therefore pass a sterility test and still carry endotoxin, which is why endotoxin is measured by its own test and removed by its own process, called depyrogenation, rather than by sterilization alone.
What is the bacterial endotoxins test (BET)?
The bacterial endotoxins test, or BET, is the official name for the compendial endotoxin assay described in USP General Chapter 85 and European Pharmacopoeia chapter 2.6.14. It covers three techniques, gel-clot, turbidimetric and chromogenic, and sets out how to confirm reagent sensitivity, calculate the maximum valid dilution, and interpret a result against an endotoxin limit. A companion chapter, USP 86, describes the same kind of test using recombinant reagents.
Does endotoxin testing still use horseshoe crabs?
Most endotoxin testing still uses LAL or the related TAL reagent, which are drawn from the blood of horseshoe crabs, and concern over bleeding mortality and the conservation of the species is one reason recombinant reagents were developed. Recombinant Factor C and recombinant cascade reagents reproduce the sensing chemistry without harvesting crab blood, and they now have compendial status through European Pharmacopoeia chapter 2.6.32 and USP General Chapter 86, so laboratories increasingly have an animal-free option.
SourcesReferences
- United States Pharmacopeia. General Chapter <85> Bacterial Endotoxins Test, USP–NF. (Reference text reproduced at drugfuture.com.) https://www.drugfuture.com/Pharmacopoeia/usp38/data/v38332/usp38nf33s2_c85.html
- United States Pharmacopeia. General Chapter <86> Bacterial Endotoxins Test Using Recombinant Reagents. Approved by the USP Microbiology Expert Committee in 2024; became official in USP–NF in May 2025.
- United States Pharmacopeia. General Chapter <151> Pyrogen Test (rabbit pyrogen test), USP–NF.
- European Pharmacopoeia. Chapter 2.6.14, Bacterial endotoxins. European Directorate for the Quality of Medicines & HealthCare (EDQM).
- European Pharmacopoeia. Chapter 2.6.32, Test for bacterial endotoxins using recombinant factor C. Available as of 1 July 2020 (EDQM). https://www.edqm.eu/en/-/recombinant-factor-c-new-ph.-eur.-chapter-available-as-of-1-july-2020
- U.S. Food and Drug Administration. Pyrogen and Endotoxins Testing: Questions and Answers — Guidance for Industry (revised 2026). https://www.fda.gov/regulatory-information/search-fda-guidance-documents/pyrogen-and-endotoxins-testing-questions-and-answers
- Poltorak, A., He, X., Smirnova, I., et al. (1998). Defective LPS signaling in C3H/HeJ and C57BL/10ScCr mice: mutations in Tlr4 gene. Science, 282(5396), 2085–2088. doi:10.1126/science.282.5396.2085
- Yamashita, K., Takeshita, N., Arita, M., et al. (2020). Roles of the clip domains of two protease zymogens in the coagulation cascade in horseshoe crabs. Journal of Biological Chemistry, 295(26), 8857–8866. doi:10.1074/jbc.RA119.012452
- Wikipedia contributors. Lipopolysaccharide (structure of LPS: O-antigen, core oligosaccharide and lipid A; CD14/TLR4/MD2 recognition; pyrogenicity). https://en.wikipedia.org/wiki/Lipopolysaccharide
- Pui, A. W. M., Ho, B., & Ding, J. L. (1997). Yeast recombinant Factor C from horseshoe crab binds endotoxin and causes bacteriostasis. Journal of Endotoxin Research, 4(6), 391–400. doi:10.1177/096805199700400602
- Li, P., Ho, B., & Ding, J. L. (2007). Recombinant Factor C competes against LBP to bind lipopolysaccharide and neutralizes the endotoxicity. Journal of Endotoxin Research, 13(3), 150–157. doi:10.1177/0968051907079573
- Ding, J. L., & Ho, B. (2010). Endotoxin Detection — from Limulus Amebocyte Lysate to Recombinant Factor C. In Subcellular Biochemistry, Springer, pp. 187–208. doi:10.1007/978-90-481-9078-2_9
- Maloney, T., Phelan, R., & Simmons, N. (2018). Saving the horseshoe crab: A synthetic alternative to horseshoe crab blood for endotoxin detection. PLOS Biology, 16(10), e2006607. doi:10.1371/journal.pbio.2006607
- Leschen, A. S., & Correia, S. J. (2010). Mortality in female horseshoe crabs (Limulus polyphemus) from biomedical bleeding and handling. Marine and Freshwater Behaviour and Physiology, 43(2), 135–147.
- bioMérieux (2024). Recombinant Factor C Methods for Endotoxin Testing: Towards Sustainable Development and Reliable Supply Chain (technical article). https://www.biomerieux.com/corp/en/blog/pharmaceutical-qc/Recombinant-Factor-Methods-Endotoxin-Testing-Sustainable-Development-Supply-Chain.html
- Shrestha, A. (2026). LAL Test (Bacterial Endotoxin Test): principle, methods, units and interpretation. Microbe Online (technical reference). https://microbeonline.com/lal-test-bacterial-endotoxin-test/
- Wikipedia contributors. Limulus amebocyte lysate (history, horseshoe-crab species, recombinant Factor C timeline and conservation). https://en.wikipedia.org/wiki/Limulus_amebocyte_lysate
For the other numbers on a research report, see Understanding Peptide COA Testing, Peptide Impurities Explained and What Is Net Peptide Content; for the two analytical methods behind purity and identity, see What Is HPLC and What Is Mass Spectrometry.
All Patriot Labs products are sold strictly for in-vitro research and laboratory use only. Not for human or veterinary consumption. This guide is educational and describes the chemistry of bacterial endotoxin and the methods used to detect it in general terms; it is not medical advice, does not describe how to use any product, and makes no claim about the endotoxin status, purity or manufacturing location of any specific product.